Crowdonomics
All companies
Care2.com, Inc. logo

Care2.com, Inc.

Operating

Retail & Consumer · Redwood City, CA

Estimated pre-money ⓘ
$23.6M
As of Sep 2017 · from Reg CF Offering (2017) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$218,267
Across 1 round since 2017
Latest share price
$1.35
Reg CF · Common Stock · Sep 2017 offering price

Financials

FY2015–FY2019 · from SEC filings · hover any figure for its source
$16.3M
$640K
2015
$1.2M
$640K
2016
$19.3M
$1.0M
2017
$18.6M
−$2.5M
2018
$15.2M
−$1.2M
2019
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2015 reviewed*
FY2016 reviewed*
FY2017 audited
FY2018 audited
FY2019
Income statement
Revenue
$16,274,549
$1,150,154
$19,346,476
$18,553,179
$15,156,674
Cost of goods sold
$15,495,861
$0
$0
$0
$0
Gross margin
5%
100%
100%
100%
100%
Net income
$639,661
$639,661
$1,009,613
-$2,529,529
-$1,198,247
Taxes paid
$8,715
$8,715
$48,039
$21,211
$20,972
Balance sheet
Cash
$2,517,569
$2,517,569
$968,565
$2,264,781
$157,748
Accounts receivable
$928,815
$928,815
$1,346,276
$269,728
$308,683
Total assets
$5,941,912
$5,941,912
$4,264,339
$4,784,081
$2,823,262
Short-term debt
$3,852,119
$3,852,119
$959,301
$1,139,920
$1,160,279
Long-term debt
$1,362,737
$1,362,737
$319,666
$1,553,337
$682,240
Total liabilities
$5,214,856
$5,214,856
$1,278,967
$2,693,257
$1,842,519
Other
Headcount
—
70
70
65
45

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$23.6M
est. pre-money
Reg CF · Common · Sep 2017

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Dec 31, 2016
Series A Preferred Stock · 28.6%Series B Preferred Stock · 25.7%Series C Preferred Stock · 23.7%Series D Preferred Stock · 19.1%Series D-1 Preferred Stock · 2.91%
ClassOutstandingVotes / shareConvertsAs convertedLiquidationLast price
Series A Preferred Stockpreferred2,500,000—1 × Common Stock28.6%1× participating · paid 1st—
Series B Preferred Stockpreferred2,241,890—1 × Common Stock25.7%1× participating · paid 1st—
Series C Preferred Stockpreferred2,017,740—1.027 × Common Stock23.7%1× participating · paid 1st—
Series D Preferred Stockpreferred1,666,419—1 × Common Stock19.1%1× participating · paid 1st—
Series D-1 Preferred Stockpreferred254,237—1 × Common Stock2.91%1× participating · paid 1st—
Total8,680,2868,733,756.11 as converted100%

Principal holders% as the filing states it, Apr 22, 2020

  • Raymond Paynter28.0%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. “As converted” counts each class in the shares it converts into. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $218.3K / $1.1MInvestors 461Est. pre-money $23.6M

Team

17 people
Randy PaynterFounder
President, CEO, & Director

Randy launched Care2 and ThePetitionSite to empower individuals to take collective action in support of social and environmental causes. He was inspired to start ThePetitionSite.com after receiving email petition-chainletters that filled inboxes in the early days of the Internet. Today, Care2′s highly engaged community starts and drives citizen and nonprofit campaigns that win local school initiatives, hold powerful corporations accountable, and protect ecosystems around the world. Before starting Care2 and ThePetitionsite, Randy co-founded one of the web’s first viral apps – electronic greeting card service eCards.com - in 1995. Randy is a proud composter, avid naturalist, and kiteboarder, and once trekked across Borneo with two Penan tribesmen. Randy loves spending time with his two young children, his wife, Nancy, and a menagerie of pets. Randy holds an AB from Harvard University and an MBA from Stanford’s Graduate School of Business. Randy has served as CEO and a Director of Care2 since 1998.

Marlin Miller
COO / CFO

Marlin Miller has served as COO and CFO at Care2 since 1999. Prior to joining Care2, he held positions at Quantum, HP and Bain & Company. He holds a BS in Engineering from the University of Michigan and an MBA from the Stanford Graduate School of Business.

Matthew McGlynn
Chief Technology Operator

Matthew McGlynn joined Care2 in 1998. As CTO, Matt oversees all aspects of technology at Care2, including leadership of initiatives in site search, SEO, and email deliverability. Matt holds a BA in Psychology from University of Notre Dame.

Eric Rardin
VP of Business Development

Eric joined Care2 in 2006. He sits on the board of directors for Humane Farm Animal Care and Marine Fish Conservation Network. Eric holds a BS from University of Wyoming, MA from University of S Carolina & a MBA from Johns Hopkins University.

Geoff Mitchell
VP of Engineering

Geoff Mitchell has been with Care2 since 2011. Prior to joining Care2, Geoff held positions with LikeList, HitPlay, Cisco and Apple. Geoff holds a degree in Business Administration from De Anza College.

Joe Baker
VP of Advocacy & Editorial

Joe Baker has been with Care2 since 2006. Prior to joining Care2, Joe held executive positions at N-TEN and Amnesty International. Joe holds a BS, MS and a Ph.D. in Engineering from UCLA.

Justin Perkins
VP of Strategic Partnerships

Justin Perkins joined Care2 in 2006. He is also the Founder of OLOMOMO Nut Company. Justin holds a BA from Principia College and an MBA in Marketing from University of Colorado Denver.

Marya Gomez
VP of Product Management

Marya Gomez has served as VP of Product Management since 2007. Prior to joining Care2, Marya managed product lines for CTB/McGraw-Hill & Critical Path. Marya holds a BA in Economics from UC Davis.

Rebecca Gerber
Sr. Director of Engagement

Rebecca Gerber has been with Care2 since July 2017. Prior to joining Care2, Rebecca was the Senior Online Strategist of Greenpeace. She holds a BA in Anthropology from UC San Diego.

Show 8 more people
Tabitha Lee
Director of Product Management

Tabitha Lee has been with Care2 since 2016. Prior to joining Care2, Tabitha held product management positions at Turnitin. She holds a BA in Comparative and World Literature from San Francisco State University.

Alison Perris
Sr. Director Brand Marketing & PR

Alison Perris joined Care2 in May 2016. Prior to joining Care2, she held roles in Marketing & Communications at Old Navy, eBay and StubHub. Alison holds a BA in Theatre from Northern Arizona University.

Frank Kocsis
Director & Secretary

Frank Kocsis was one of the original investors in Care2 in 1998. Frank has been Director & Secretary at Care2 since 1999. He holds a BS in Accounting from UCLA as well as a MBA from the University of Southern California.

Gerald Marxman
Board Director

Gerald Marxman was one of the original investors in Care2 in 1998. Gerald has been Director at Care2 since 1999. He holds a BA from Monmouth College, a BS & MS in Mechanical Engineering from Case Western Reserve University and a PhD in mechanical engineering and physics from CalTech.

Juliana Wang
Controller

Juliana Wang joined Care2 in August 2017. Prior to joining Care2, she held the role of Senior Accounting Manager at Verity Health System since 2012. Juliana holds a BS in commerce from Santa Clara University.

Megan Zehnder
Managing Editor

Megan Zehnder joined Care2 in 2009. Megan works with her editorial team to provide meaningful content that empowers readers to improve their lives and their communities. Megan holds her BA in English from Santa Clara University.

Natasha Nummedal
Campaigns Director

Natasha Nummedal joined Care2 in 2007. Prior to joining Care2, Natasha lead urgent action programming for Amnesty International. Natasha holds a BS from LSU and a MS from University of Colorado, Boulder.

Sabrina Modelle-Carlberg
Creative Director

Sabrina Modelle-Carlberg joined Care2 in 2007. Sabrina leads all graphic and design efforts for Care2. Prior to joining Care2, Sabrina held roles at Common Knowledge & Whole Earth Network.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not required3+ reports filed & assets ≤ $10M

Filed 3 of 9 annual reports (FY2017–FY2025)

461 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 22, 20200001716813-20-000002
    EDGAR
  • Form C-ARMay 1, 20190001716813-19-000003
    EDGAR
  • Form C-ARApr 30, 20180001665160-18-000355
    EDGAR
  • Form C-UDec 15, 20170001665160-17-000690
    EDGAR
  • Form CSep 26, 20170001665160-17-000424
    EDGAR
Source: SEC EDGARCIK 0001716813DEShare price $1.35Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.